Deacon S W, Peterson J R
Division of Basic Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Handb Exp Pharmacol. 2008(186):431-60. doi: 10.1007/978-3-540-72843-6_18.
The Rho family of small GTP-binding proteins can activate a large number of downstream effectors and participate in a wide variety of biological processes, including cell motility, membrane trafficking, cell polarity, gene transcription, and mitosis. Specific small-molecule inhibitors of individual effector proteins downstream of Rho GTPases would be powerful tools to elucidate the contributions of particular effectors to these processes. In this chapter we describe the identification of a chemical inhibitor of a Rho effector and scaffolding protein neural-Wiskott-Aldrich syndrome protein (N-WASP), and the discovery of its novel mechanism of action, stabilization of N-WASP's native autoinhibited conformation. Inasmuch as several other Rho GTPase effectors are regulated by autoinhibition, we discuss how this regulatory mechanism could be exploited by small molecules to develop highly specific inhibitors of other Rho GTPase effectors. We illustrate this concept with the Rac/Cdc42 effector p21-activated kinase (Pak1) and the Rho effector mammalian diaphanous-related formin (mDia1).
小GTP结合蛋白的Rho家族可激活大量下游效应器,并参与多种生物学过程,包括细胞运动、膜运输、细胞极性、基因转录和有丝分裂。Rho GTP酶下游单个效应蛋白的特异性小分子抑制剂将是阐明特定效应器对这些过程贡献的有力工具。在本章中,我们描述了一种Rho效应器和支架蛋白神经威斯科特-奥尔德里奇综合征蛋白(N-WASP)化学抑制剂的鉴定,以及其新作用机制的发现,即稳定N-WASP的天然自抑制构象。鉴于其他几种Rho GTP酶效应器也受自抑制调节,我们讨论了小分子如何利用这种调节机制来开发其他Rho GTP酶效应器的高度特异性抑制剂。我们用Rac/Cdc42效应器p21激活激酶(Pak1)和Rho效应器哺乳动物双调蛋白相关成束蛋白(mDia1)来说明这一概念。